$ARNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARENA PHARMACEUTICALS INC. Get notifications about new insider transactions in ARENA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | A | 3.72 | 45,000 | 167,400 | 45,000 | |
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Grant | A | 0.00 | 15,000 | 0 | 58,074 | 43.1 K to 58.1 K (+34.82 %) |
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Option Exercise | A | 3.72 | 165,000 | 613,800 | 165,000 | |
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Grant | A | 0.00 | 55,000 | 0 | 496,564 | 441.6 K to 496.6 K (+12.46 %) |
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 3.72 | 75,000 | 279,000 | 75,000 | |
| Dec 17 2014 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Grant | A | 0.00 | 25,000 | 0 | 508,000 | 483 K to 508 K (+5.18 %) |
| Sep 19 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | M | 1.49 | 100,000 | 149,000 | 200,000 | |
| Sep 19 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Buy | M | 1.49 | 100,000 | 149,000 | 441,039 | 341 K to 441 K (+29.32 %) |
| Aug 27 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Gift | G | 0.00 | 10,000 | 0 | 563,704 | 573.7 K to 563.7 K (-1.74 %) |
| Aug 27 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Gift | G | 0.00 | 10,000 | 0 | 573,704 | 583.7 K to 573.7 K (-1.71 %) |
| Jul 03 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Sell | S | 5.85 | 223,525 | 1,308,582 | 361,039 | 584.6 K to 361 K (-38.24 %) |
| Jun 27 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | M | 5.46 | 2,473 | 13,503 | 0 | |
| Jun 27 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Sell | S | 5.85 | 2,473 | 14,467 | 94,112 | 96.6 K to 94.1 K (-2.56 %) |
| Jun 27 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | M | 5.46 | 2,473 | 13,503 | 96,585 | 94.1 K to 96.6 K (+2.63 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Grant | A | 0.00 | 25,384 | 0 | 64,112 | 38.7 K to 64.1 K (+65.54 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 25,384 | 0 | 44,112 | 18.7 K to 44.1 K (+135.54 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Grant | A | 0.00 | 25,384 | 0 | 94,112 | 68.7 K to 94.1 K (+36.93 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Grant | A | 0.00 | 25,384 | 0 | 45,112 | 19.7 K to 45.1 K (+128.67 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Grant | A | 0.00 | 25,384 | 0 | 54,112 | 28.7 K to 54.1 K (+88.36 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Grant | A | 0.00 | 25,384 | 0 | 108,260 | 82.9 K to 108.3 K (+30.63 %) |
| Jun 16 2014 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Grant | A | 0.00 | 25,384 | 0 | 49,012 | 23.6 K to 49 K (+107.43 %) |
| May 14 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 45,000 | 67,050 | 145,000 | |
| May 14 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 7.05 | 45,000 | 317,358 | 102,187 | 147.2 K to 102.2 K (-30.57 %) |
| May 14 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 45,000 | 67,050 | 147,187 | 102.2 K to 147.2 K (+44.04 %) |
| May 07 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | M | 4.31 | 4,176 | 17,999 | 0 | |
| May 07 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Sell | S | 7.00 | 4,176 | 29,232 | 68,728 | 72.9 K to 68.7 K (-5.73 %) |
| May 07 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | M | 4.31 | 4,176 | 17,999 | 72,904 | 68.7 K to 72.9 K (+6.08 %) |
| Apr 24 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | M | 4.11 | 11,900 | 48,909 | 2,699 | |
| Apr 24 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | M | 4.11 | 25,000 | 102,750 | 0 | |
| Apr 24 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Sell | S | 6.31 | 36,900 | 232,754 | 82,876 | 119.8 K to 82.9 K (-30.81 %) |
| Apr 24 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Buy | M | 4.11 | 11,900 | 48,909 | 119,776 | 107.9 K to 119.8 K (+11.03 %) |
| Apr 24 2014 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Buy | M | 4.11 | 25,000 | 102,750 | 107,876 | 82.9 K to 107.9 K (+30.17 %) |
| Apr 15 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 6.16 | 10,000 | 61,600 | 0 | |
| Apr 15 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 4.11 | 25,000 | 102,750 | 0 | |
| Apr 15 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Sell | S | 6.22 | 35,000 | 217,763 | 18,728 | 53.7 K to 18.7 K (-65.14 %) |
| Apr 15 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 6.16 | 10,000 | 61,600 | 53,728 | 43.7 K to 53.7 K (+22.87 %) |
| Apr 15 2014 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 4.11 | 25,000 | 102,750 | 43,728 | 18.7 K to 43.7 K (+133.49 %) |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | M | 6.30 | 1,905 | 12,002 | 0 | |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Sell | S | 6.45 | 1,905 | 12,287 | 68,728 | 70.6 K to 68.7 K (-2.70 %) |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | M | 6.30 | 1,905 | 12,002 | 70,633 | 68.7 K to 70.6 K (+2.77 %) |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | M | 6.30 | 60,000 | 378,000 | 0 | |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Sell | S | 6.37 | 60,000 | 382,014 | 35,000 | 95 K to 35 K (-63.16 %) |
| Apr 02 2014 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Buy | M | 6.30 | 60,000 | 378,000 | 95,000 | 35 K to 95 K (+171.43 %) |
| Mar 05 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 25,000 | 37,250 | 190,000 | |
| Mar 05 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 7.01 | 100 | 701 | 101,794 | 101.9 K to 101.8 K (-0.10 %) |
| Mar 05 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 7.01 | 24,900 | 174,549 | 101,894 | 126.8 K to 101.9 K (-19.64 %) |
| Mar 05 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 25,000 | 37,250 | 126,794 | 101.8 K to 126.8 K (+24.56 %) |
| Jan 17 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | M | 6.00 | 100,000 | 600,000 | 0 | |
| Jan 17 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Sell | S | 7.81 | 100,000 | 781,260 | 583,704 | 683.7 K to 583.7 K (-14.63 %) |
| Jan 17 2014 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Buy | M | 6.00 | 100,000 | 600,000 | 683,704 | 583.7 K to 683.7 K (+17.13 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | M | 6.00 | 5,000 | 30,000 | 0 | |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | M | 6.00 | 25,000 | 150,000 | 0 | |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Sell | S | 6.15 | 30,000 | 184,500 | 68,728 | 98.7 K to 68.7 K (-30.39 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | M | 6.00 | 5,000 | 30,000 | 98,728 | 93.7 K to 98.7 K (+5.33 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | M | 6.00 | 25,000 | 150,000 | 93,728 | 68.7 K to 93.7 K (+36.38 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | M | 6.00 | 25,000 | 150,000 | 0 | |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Sell | S | 6.10 | 25,000 | 152,500 | 23,628 | 48.6 K to 23.6 K (-51.41 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Buy | M | 6.00 | 25,000 | 150,000 | 48,628 | 23.6 K to 48.6 K (+105.81 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 6.00 | 33,334 | 200,004 | 0 | |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 6.10 | 33,334 | 203,337 | 101,794 | 135.1 K to 101.8 K (-24.67 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 6.00 | 33,334 | 200,004 | 135,128 | 101.8 K to 135.1 K (+32.75 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | M | 6.00 | 33,332 | 199,992 | 0 | |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Sell | S | 6.25 | 33,332 | 208,325 | 483,000 | 516.3 K to 483 K (-6.46 %) |
| Jan 13 2014 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Buy | M | 6.00 | 33,332 | 199,992 | 516,332 | 483 K to 516.3 K (+6.90 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | A | 5.52 | 60,000 | 331,200 | 60,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Grant | A | 0.00 | 20,000 | 0 | 35,000 | 15 K to 35 K (+133.33 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | A | 5.52 | 60,000 | 331,200 | 60,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 35,000 | 15 K to 35 K (+133.33 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 5.52 | 100,000 | 552,000 | 100,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Grant | A | 0.00 | 30,000 | 0 | 101,420 | 71.4 K to 101.4 K (+42.01 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | A | 5.52 | 60,000 | 331,200 | 60,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Grant | A | 0.00 | 20,000 | 0 | 40,820 | 20.8 K to 40.8 K (+96.06 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 5.52 | 180,000 | 993,600 | 180,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Grant | A | 0.00 | 60,000 | 0 | 583,286 | 523.3 K to 583.3 K (+11.47 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Gift | G | 0.00 | 20,000 | 0 | 523,286 | 543.3 K to 523.3 K (-3.68 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Gift | G | 0.00 | 5,000 | 0 | 542,882 | 547.9 K to 542.9 K (-0.91 %) |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 5.52 | 100,000 | 552,000 | 100,000 | |
| Dec 18 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Grant | A | 0.00 | 30,000 | 0 | 483,000 | 453 K to 483 K (+6.62 %) |
| Nov 13 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 20,000 | 29,800 | 215,000 | |
| Nov 13 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 5.19 | 20,000 | 103,710 | 71,420 | 91.4 K to 71.4 K (-21.88 %) |
| Nov 13 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 20,000 | 29,800 | 91,420 | 71.4 K to 91.4 K (+28.00 %) |
| Sep 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | M | 1.81 | 50,000 | 90,500 | 450,000 | |
| Sep 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | M | 1.49 | 150,000 | 223,500 | 150,000 | |
| Sep 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Sell | S | 6.31 | 200,000 | 1,261,020 | 453,000 | 653 K to 453 K (-30.63 %) |
| Sep 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Buy | M | 1.81 | 50,000 | 90,500 | 653,000 | 603 K to 653 K (+8.29 %) |
| Sep 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Buy | M | 1.49 | 150,000 | 223,500 | 603,000 | 453 K to 603 K (+33.11 %) |
| Sep 06 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 20,000 | 29,800 | 235,000 | |
| Sep 06 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 6.54 | 20,000 | 130,726 | 71,046 | 91 K to 71 K (-21.97 %) |
| Sep 06 2013 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 20,000 | 29,800 | 91,046 | 71 K to 91 K (+28.15 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Grant | A | 0.00 | 18,728 | 0 | 38,728 | 20 K to 38.7 K (+93.64 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 18,728 | 0 | 18,728 | 0 to 18.7 K |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Grant | A | 0.00 | 18,728 | 0 | 23,628 | 4.9 K to 23.6 K (+382.20 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Grant | A | 0.00 | 18,728 | 0 | 68,728 | 50 K to 68.7 K (+37.46 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Grant | A | 0.00 | 18,728 | 0 | 19,728 | 1,000 to 19.7 K (+1,872.80 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Grant | A | 0.00 | 18,728 | 0 | 28,728 | 10 K to 28.7 K (+187.28 %) |
| Jun 11 2013 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Grant | A | 0.00 | 18,728 | 0 | 98,112 | 79.4 K to 98.1 K (+23.59 %) |
| May 21 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | M | 1.81 | 46,250 | 83,713 | 138,750 | |
| May 21 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | M | 1.28 | 37,500 | 48,000 | 37,500 | |
| May 21 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Sell | S | 8.00 | 83,750 | 670,000 | 15,000 | 98.8 K to 15 K (-84.81 %) |
| May 21 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Buy | M | 1.81 | 46,250 | 83,713 | 98,750 | 52.5 K to 98.8 K (+88.10 %) |
| May 21 2013 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Buy | M | 1.28 | 37,500 | 48,000 | 52,500 | 15 K to 52.5 K (+250.00 %) |
| Apr 03 2013 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | M | 1.81 | 71,250 | 128,963 | 213,750 | |
| Apr 03 2013 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Sell | S | 8.21 | 71,250 | 585,126 | 19,570 | 90.8 K to 19.6 K (-78.45 %) |
| Apr 03 2013 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Buy | M | 1.81 | 71,250 | 128,963 | 90,820 | 19.6 K to 90.8 K (+364.08 %) |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Option Exercise | A | 8.87 | 50,000 | 443,500 | 50,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | Audet Craig Michael | SVP, Opn & Head Glo ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Option Exercise | A | 8.87 | 50,000 | 443,500 | 50,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | SVP & Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 8.87 | 100,000 | 887,000 | 100,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Grant | A | 0.00 | 30,000 | 0 | 69,943 | 39.9 K to 69.9 K (+75.11 %) |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | A | 8.87 | 50,000 | 443,500 | 50,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Grant | A | 0.00 | 15,000 | 0 | 18,382 | 3.4 K to 18.4 K (+443.52 %) |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 8.87 | 180,000 | 1,596,600 | 180,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Grant | A | 0.00 | 60,000 | 0 | 546,007 | 486 K to 546 K (+12.35 %) |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Gift | G | 0.00 | 13,875 | 0 | 485,382 | 499.3 K to 485.4 K (-2.78 %) |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 8.87 | 100,000 | 887,000 | 100,000 | |
| Dec 17 2012 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Grant | A | 0.00 | 30,000 | 0 | 453,000 | 423 K to 453 K (+7.09 %) |
| Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | M | 1.48 | 50,000 | 74,000 | 150,000 | |
| Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Sell | S | 8.32 | 50,000 | 415,980 | 3,382 | 53.4 K to 3.4 K (-93.66 %) |
| Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Buy | M | 1.48 | 50,000 | 74,000 | 53,382 | 3.4 K to 53.4 K (+1,478.42 %) |
| Jul 09 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Sell | S | 11.00 | 10,000 | 110,000 | 2,763 | 12.8 K to 2.8 K (-78.35 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 4.01 | 22,300 | 89,423 | 15,001 | |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 1.49 | 45,000 | 67,050 | 255,000 | |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 3.25 | 30,000 | 97,500 | 70,000 | |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 4.01 | 22,699 | 91,023 | 37,301 | |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | M | 6.00 | 16,666 | 99,996 | 33,334 | |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 10.05 | 22,300 | 224,115 | 39,588 | 61.9 K to 39.6 K (-36.03 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 4.01 | 22,300 | 89,423 | 61,888 | 39.6 K to 61.9 K (+56.33 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 10.04 | 39,365 | 395,134 | 39,588 | 79 K to 39.6 K (-49.86 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Sell | S | 9.96 | 95,000 | 946,048 | 78,953 | 174 K to 79 K (-54.61 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 1.49 | 45,000 | 67,050 | 173,953 | 129 K to 174 K (+34.90 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 3.25 | 30,000 | 97,500 | 128,953 | 99 K to 129 K (+30.32 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 4.01 | 22,699 | 91,023 | 98,953 | 76.3 K to 99 K (+29.77 %) |
| Jul 03 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Buy | M | 6.00 | 16,666 | 99,996 | 76,254 | 59.6 K to 76.3 K (+27.97 %) |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Jun 18 2012 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 8.40 | 48,000 | 403,200 | 48,000 | |
| Mar 30 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Option Exercise | M | 1.49 | 6,250 | 9,313 | 18,750 | |
| Mar 30 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Sell | S | 3.01 | 4,550 | 13,696 | 4,800 | 9.4 K to 4.8 K (-48.66 %) |
| Mar 30 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Sell | S | 3.04 | 6,250 | 19,001 | 9,350 | 15.6 K to 9.4 K (-40.06 %) |
| Mar 30 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Buy | M | 1.49 | 6,250 | 9,313 | 15,600 | 9.4 K to 15.6 K (+66.84 %) |
| Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Option Exercise | A | 1.81 | 40,000 | 72,400 | 40,000 | |
| Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | EVP, General Counse ... | Option Exercise | A | 1.81 | 500,000 | 905,000 | 500,000 | |
| Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | Sr. VP & Chief Medi ... | Option Exercise | A | 1.81 | 200,000 | 362,000 | 200,000 | |
| Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 1.81 | 285,000 | 515,850 | 285,000 | |
| Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | EVP & Chief Scienti ... | Option Exercise | A | 1.81 | 500,000 | 905,000 | 500,000 |